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Abstract
Background:  Compared with their ovarian counterparts, serous borderline tumors of the
fallopian tube are uncommon, with limited experience about their clinical behaviour. We present
a case of serous borderline tumor of the fallopian tube with unusual presentation and summarise
all the published cases to date.
Case presentation: A case of serous borderline tumor of the fallopian tube in a 34-year old
patient is presented, incidentally found during routine gynecologic examination. At laparoscopy the
tumor was unusualy presented as hematosalpinx and was treated by salpingectomy. Cell-cycle
analysis of the tumor tissue revealed a diploid DNA content and a low S-phase fraction. There was
no evidence of the disease during the follow-up period of 4.6 years.
Conclusion: The current case and review of the literature suggest salpingectomy as the optimal
treatment for patients with serous borderline tumor of the fallopian tube.
Background
Compared with their ovarian counterparts, serous border-
line tumors (SBTs) of the fallopian tube are uncommon,
with limited experience about their clinical behaviour.
Herein we report a case of SBT of the fallopian tube in a
young woman that was unusualy presented as hematos-
alpinx during the laparoscopic operation.
Case presentation
A 34-year old multigravida was found to have right adn-
exal mass on her routine gynecologic examination. Her
previous medical history was uneventfull and Pap smear
was normal. Transvaginal ultrasonography identified a
cystic mass adjacent to the right ovary. Serum CA 125 was
5.1 U/ml (reference range: < 35 U/ml). At laparoscopy a
dilated fallopian tube with bluish discoloration was
found. The contralateral fallopian tube, ovaries and uterus
were unremarkable. Exploration of the abdomino-pelvic
cavity revealed smooth and shiny peritoneal surphace.
Obtained peritoneal and pelvic washing were negative.
Fine needle aspiration of dilated part of the fallopian tube
revealed a 4 ml of bloody content. Cytological findings
were consistent with hematosalpinx. Right salpingectomy
was performed without using endoscopic bag. The patient
was followed up by means of ultrasonography and serum
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CA 125 for 4.6 years. During this period she had no evi-
dence of the disease.
Grossly, a 7.0 cm long fallopian tube was irregularly
dilated up to 4.4 cm in diameter at the ampulary region.
The fimbriae were intact. The serosal surphace was
smooth. Sections of the dilated part of the fallopian tube
revealed a cystic tumor with focally yellow to tan, soft
papillary excrescences protruding into the lumen (Fig. 1A)
and foci of intracystic hemorrhage. On microscopic exam-
ination the papillae were covered by serous type of epithe-
lium, displaying stratification and budding with focal
nuclear atypia (Fig. 1B). Three types of cells were recog-
nised; ciliated cells, hob-nail cells and mesothelium-like
cells. Small foci of tumor tissue necroses and hemorrhage
were noted. There was no invasion of the supportive
stroma of the papillae or into the fallopian tube wall.
Focus of endosalpingiosis within the adjacent mesos-
alpinx was found. DNA analysis determined by flow
cytometry paraffin technique revealed DNA diploid
tumor with low S-phase fraction of 6.5 %.
Conclusion
To the best of our knowledge, only 6 cases of SBTs of the
fallopian tube have been previously reported in the litera-
ture. Clinico-pathologic features of these tumors, includ-
ing the current case are summarized in Table 1. The first
case [1] that was originally reported as adenocarcinoma,
Alvaredo-Cabrero et al [2] considered it to be a tumor of
borderline malignancy. Age of the patients ranged from
19 to 34 (average 29.2) years. Four tumors were found
incidentaly [2-4], three were presented with abdominal
pain [1,5,6]. Serum CA 125 was elevated in one case [5].
All the tumors were unilateral, measuring from 1.7 – 13
cm. Three of them were located at the fimbriated end, two
at the ampulary region, and in one case the whole tube
was enlarged. Grossly, all the tumors were cystic with
internal papillation, except one that was solid [5]. Histo-
logicaly the epithelium showed the morphology of bor-
derline serous tumors, according to the criteria applied in
the ovary.
SBTs were treated exclusively by surgery, most of them by
unilateral salpingectomy. Complete staging/restaging was
performed only in one case [5], where except salpingo-
oophorectomy, contralateral ovarian biopsy, partial
omentectomy and appendectomy were performed. Perito-
neal and pelvic washing were obtained and multiple pel-
vic lymph nodes were sampled. Ten months later,
contralateral ovary due to adenofibroma was removed
and peritoneal and pelvic washing were obtained. The
patient was without evidence of the disease during the fol-
low-up period of 6 years.
Seidman and Kurman [7] reviewed 97 reports that
included 4,129 patients with ovarian SBTs. They con-
cluded that surgical-pathological stage and type of extrao-
varian disease (invasive versus noninvasive implants)
were the most powerful prognostic indicators for these
tumors. Survival rate for stage I SBTs was almost 100 %
(99.5 %). Survival for advanced stage SBTs with noninva-
Composite figure of serous borderline tumor of the fallopian tube Figure 1
Composite figure of serous borderline tumor of the fallopian tube. A) Papillary tumor protruding into the lumen of 
the fallopian tube (low magnification). There is no invasion into the wall of the tube (top). B) Stratification and budding of the 
epithelium with focal nuclear atypia (high magnification).BMC Cancer 2005, 5:129 http://www.biomedcentral.com/1471-2407/5/129
Page 3 of 4
(page number not for citation purposes)
sive and invasive implants were 95.3 % and 66 %
respectively.
In order to predict the behaviour of the SBT in current
case, similary to the ovarian tumors, DNA ploidy was
determined. In our case the tumor was diploid with low S-
phase fraction of 6.3 %. DNA ploidy was found to be
important prognostic factor in 321 patients with ovarian
borderline tumors (BTs) [8]. Aneuploidy was associated
with older age, more advanced disease and non-serous
histologic type as well. However, although aneuploidy
correlated with higher stage in a study of 42 ovarian BTs,
ploidy/DNA index could not predict which borderline
tumors would behave in a more aggressive fashion [9].
Analysis of 49 advanced stage ovarian SBTs revealed no
correlation between DNA content and frequency of tumor
recurrence [10]. No death occurred in a subset of patients
with aneuploid tumors. The patients with aneuploid
tumors were more likely to have received adjuvant chem-
otherapy, that could affect the results.
Four additional cases of BTs of the fallopian tube were
reported. Three had mucinous type of epithelium [11-13]
and one was endometrioid borderline tumour [2]. The
mean age of patients with mucinous borderline tumors
(MBT) was 54 years. Presented symptoms included consti-
pation [11] and pelvic mass [11,13]. MBT was bilateral in
one case [13]. Two cases were associated with pseu-
domyxoma peritonei [11,12]. Follow-up informations
were not available in these cases.
The unique case of borderline endometrioid tumor was
reported by Alvaredo-Cabrero et al in a serie of 20 cases of
tumors of the fimbriated end of the fallopian tube [2]. The
tumor was borderline adenofibroma and contained large
number of endometrioid-type glands with focal villoglan-
dular pattern separated by a fibromatous stroma. No fol-
low-up information was available.
In conclusion, confinement to the tube as well as normal
DNA content of the tumor may indicate a benign clinical
behaviour of the SBTs of fallopian tube, suggesting unilat-
eral salpingectomy as the optimal treatment for these
young patients. However, long term follow-up and more
cases are needed to make definitive conclusions.
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Table 1: Serous borderline tumors of the fallopian tube: clinical and pathological features of 7 cases.
Case no. 
(reference no.)
Original 
diagnosis
Age (yr) Symptoms Procedure Localization Gross finding Follow-up
1. (1) papillary 
cystadenocarcin
oma
19 lower-guadrant 
pain, coul-de-sac 
mass
partial 
salpingectomy
fimbriated end 4 cm, cystic with 
papillations
18 mo, WED
2. (3) borderline 
cystadenofibro
ma
32 IF during an early 
pregnancy
salpingectomy ampulary region 2.5 cm, cystic with 
papillations
WED after 
unspecified time
3. (5) borderline 
papillary serous 
tumor
31 abdominal pain, 
elevated CA 125
salpingo-
oophorectomy, 
ovarian biopsy, 
partial 
omentectomy
protruding from 
the fimbria
6 cm, solid 
polipoid mass with 
cauliflower-like 
surface
6 yr, WED
4. (2) borderline 
serous tumor
NS IF during an elective 
operation
NS fimbriated end 1.7 cm, cystic with 
papillations
2.4 yr, well
5. (4) serous tumor of 
low malignant 
potential
31 IF on routine 
gynecologic 
examination
salpingectomy entire tube 13 cm, cystic with 
papillations
not available
6. (6) serous tumor of 
low malignant 
potential
28 lower quadrant pain salpingectomy NS 5 cm, cystic with 
papillations
recently found
7. (current case) serous tumor of 
borderline 
malignancy
34 IF on routine 
gynecologic 
examination
salpingectomy ampulary region 4.4 cm, cystic with 
papillations
4.6 yr, WED
NS, not specified; IF, incidental finding; WED, without evidence of the disease.Publish with BioMed Central    and   every 
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